SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 113 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $2,016,000 | +82.4% | 669,770 | +48.5% | 0.00% | +100.0% |
Q1 2015 | $1,105,000 | +3583.3% | 451,090 | +3788.7% | 0.00% | – |
Q4 2014 | $30,000 | -73.2% | 11,600 | -26.1% | 0.00% | – |
Q3 2014 | $112,000 | +111.3% | 15,700 | +91.5% | 0.00% | – |
Q2 2014 | $53,000 | +1225.0% | 8,200 | +1133.1% | 0.00% | – |
Q1 2014 | $4,000 | -95.3% | 665 | -96.3% | 0.00% | – |
Q4 2013 | $85,000 | -26.1% | 18,019 | -22.1% | 0.00% | – |
Q3 2013 | $115,000 | -24.3% | 23,119 | -20.9% | 0.00% | – |
Q2 2013 | $152,000 | – | 29,243 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lamond Capital Partners LLC | 1,320,000 | $9,425,000 | 10.46% |
RA Capital Management | 4,869,261 | $34,767,000 | 4.11% |
GREAT POINT PARTNERS LLC | 400,000 | $2,856,000 | 1.23% |
Healthcare Value Capital, LLC | 100,000 | $714,000 | 0.69% |
DSC Advisors, L.P. | 175,000 | $1,250,000 | 0.63% |
Quantitative Systematic Strategies LLC | 107,416 | $803,000 | 0.47% |
Visium Asset Management, LP | 4,093,890 | $29,230,000 | 0.43% |
Rhenman & Partners Asset Management AB | 201,171 | $1,436,000 | 0.42% |
EAM Investors, LLC | 277,807 | $1,984,000 | 0.40% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 354,861 | $2,534,000 | 0.39% |